
Pathalys Pharma
Developer of advanced therapeutics designed to address unmet needs in the management of late-stage chronic kidney diseases. The company creates upacicalcet, which is a novel calcimimetic with the pote...
Valuation
$295M
Latest known
Share Price
N/A
Total Raised
$266M
Last Round
N/A